GT Biopharma

0.4818
-0.0571
-10.60%
GTBP
 0.5262 0.5262 63.04万股总市值 1284.10万
 0.4818 2.37% 31.63万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
用户头像
GT Biopharma(GTBP)
02-02 19:15  
$GT Biopharma(GTBP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-26-000420  Act: 33  Size: 2 KB 网页链接
用户头像
GT Biopharma(GTBP)
01-31 06:15  
$GT Biopharma(GTBP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-26-004547  Act: 33  Size: 347 KB 网页链接
用户头像
GT Biopharma(GTBP)
01-22 05:25  
$GT Biopharma(GTBP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-26-003089  Act: 33  Size: 995 KB 网页链接
用户头像
GT Biopharma(GTBP)
01-09 05:25  
$GT Biopharma(GTBP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-26-000976  Act: 33  Size: 10 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-12-03 19:15  
$GT Biopharma(GTBP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003476  Act: 33  Size: 2 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-12-03 06:25  
$GT Biopharma(GTBP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-25-025796  Act: 33  Size: 314 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-11-27 05:35  
$GT Biopharma(GTBP)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001493152-25-025162  Act: 34  Size: 207 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-11-15 05:05  
$GT Biopharma(GTBP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-25-023400  Act: 34  Size: 6 MB 网页链接
用户头像
GT Biopharma(GTBP)
2025-11-14 22:15  
$GT Biopharma(GTBP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-25-022631  Act: 34  Size: 238 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-10-25 04:25  
$GT Biopharma(GTBP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-25-019296  Act: 33  Size: 1 MB 网页链接
用户头像
GT Biopharma(GTBP)
2025-09-27 04:25  
$GT Biopharma(GTBP)$ 8-K Current report, items 3.03 and 9.01 Accession Number: 0001493152-25-015725  Act: 34  Size: 204 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-09-24 05:35  
$GT Biopharma(GTBP)$ 8-K Current report, items 3.03 and 9.01 Accession Number: 0001493152-25-014684  Act: 34  Size: 222 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-09-09 05:55  
$GT Biopharma(GTBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641172-25-026890  Size: 10 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-09-09 05:55  
$GT Biopharma(GTBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641172-25-026893  Size: 5 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-09-09 05:55  
$GT Biopharma(GTBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641172-25-026891  Size: 5 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-09-09 05:55  
$GT Biopharma(GTBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641172-25-026892  Size: 5 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-09-09 05:55  
$GT Biopharma(GTBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641172-25-026894  Size: 7 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-08-30 04:25  
$GT Biopharma(GTBP)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001493152-25-012479  Act: 34  Size: 230 KB 网页链接
用户头像
GT Biopharma(GTBP)
2025-08-15 04:15  
$GT Biopharma(GTBP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-25-011971  Act: 34  Size: 7 MB 网页链接
用户头像
GT Biopharma(GTBP)
2025-07-31 04:15  
$GT Biopharma(GTBP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001641172-25-021546  Size: 3 KB 网页链接